Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1850
-0.0100 (-5.13%)
Apr 17, 2026, 3:07 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 23.76 million as of April 17, 2026. Its market cap has decreased by -76.81% in one year.
Market Cap
23.76M
Enterprise Value
18.73M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 23.76M, an increase of 24.91%. That is a compound annual growth rate of 4.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 23.76M | -37.29% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imugene | 55.34M |
| Prescient Therapeutics | 54.68M |
| Entropy Neurodynamics | 45.28M |
| Proteomics International Laboratories | 41.30M |
| EZZ Life Science Holdings | 39.07M |
| NeuroScientific Biopharmaceuticals | 38.25M |
| Avecho Biotechnology | 34.90M |
| Algorae Pharmaceuticals | 24.28M |